Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Mucositis: early-phase trial registry
2 of 5 indexed Mucositis trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #3,391 of 28,707 conditions by registered trial count.
5 US clinical trials · 2 currently recruiting · #3,391 of 28,707 conditions by registered trial count
Mucositis: 5 US clinical trials tracked, 2 recruiting.
Mucositis is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Barbara Ann Karmanos Cancer Institute, running 2 of these trials.
Enrollment posture brief
Registry condition mucositis
OPEN 2 | RECR 40% | LATE 0 | EARLY 2 | RANK #3391 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Achondroplasia (40% recruiting · 10 trials)
Mucositis lists 2 open slots (40% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Mucositis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Mucositis is recruiting below its size-band peers.
2 of 5 indexed trials (40%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Mucositis research.
Barbara Ann Karmanos Cancer Institute accounts for 2 of 5 trials (40%). 4 distinct sponsors appear on at least one study for this condition label.
-
Most Mucositis trials plan to enrol fewer than 100 people.
Median target enrolment is 32 among the 5 trials that report a genuine target (sentinel values excluded). 4 of those (80%) plan for fewer than 100 participants.
-
Mucositis research is mostly interventional.
5 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
5 total, page 1 of 1
Treatment of Radiation and Cisplatin Induced Toxicities with Tempol
Matrix Biomed
NCT03480971
The Effect Of Enamel Matrix Derivatives On Gingival Tissue Thickness
The University of Texas Health Science Center at San Antonio
NCT07053969
Melphalan and Palifermin in Treating Patients Undergoing An Autologous Peripheral Stem Cell Transplant for Stage II or III Multiple Myeloma
Barbara Ann Karmanos Cancer Institute
NCT00482846
Sensory Evaluation of Oral Nutrition Supplements in Patients at Risk for Mucositis Undergoing Cancer Treatment
Rutgers, The State University of New Jersey
NCT03228147
Low-Level Laser Therapy for Prevention of Oral Mucositis
Barbara Ann Karmanos Cancer Institute
NCT02723604
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Mucositis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Mucositis trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Mucositis page
5 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Mucositis trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Barbara Ann Karmanos Cancer Institute sponsors the most Mucositis trials on record, review their full trial history before evaluating a specific study. See Barbara Ann Karmanos Cancer Institute's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Mucositis condition card totals 5 registered trials; most-linked intervention autologous peripheral blood stem cell transplantation; top US site state Michigan. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.